4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-020480
EVP & Chief Financial Officer disposed of 2,500 shares (other)
- EVP & Chief Financial Officer acquired 2,500 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Byrne Jason EVP & Chief Financial Officer | 2026-03-20 | Other disposition | −2,500 | 160,115 | D | ||
| O'Byrne Jason EVP & Chief Financial Officer | 2026-03-20 | Other acquisition | +2,500 | 2,500 | I |
Loading xslF345X06/wk-form4_1774295389.xml…